An estimated 240 million people worldwide carry a chronic hepatitis B infection, and more than 780,000 die each year due to complications like cirrhosis and liver cancer.1
There is still limited access to proper diagnosis and treatment of hepatitis B, and many people are diagnosed only after they already have advanced liver disease.
Roche continues to search for new and innovative ways to prevent, diagnose and treat HBV. Our highly sensitive, accurate assays play a critical role in successfully managing patients with chronic HBV infections. They can also be used to screen blood, plasma and organ donors for the infection.
- World Health Organization (WHO). Fact sheet No. 204: Hepatitis B. http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed May 13, 2016.